Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Urinary TIMP-2/ IGFBP7 in Intra-Arterial Contrast-Associated Acute Kidney Injury

NCT04163250 is registered in ClinicalTrials.gov with Eva de Miguel Balsa as lead sponsor.

NCT NCT04163250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04163250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Urinary TIMP-2/ IGFBP7 in Intra-Arterial Contrast-Associated Acute Kidney Injury
Lead sponsor
Eva de Miguel Balsa
Phase
Observational
Overall status
Completed
Start date
June 1, 2019
Completion date
March 30, 2021
Enrollment
194 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast-induced nephropathy